Mr. Chang-Won Jeong is a partner of Shin & Kim. Mr. Jeong specializes in litigation and advice for intellectual property, trade secret, IT (Information Technology), and technologies.

Before being admitted to the Korean bar, Mr. Jeong was a qualified patent attorney with a wide range of experiences with large corporations such as Samsung, LG, and Hyundai Mobis in domestic and overseas patent applications and registrations.

Mr. Jeong worked as a lawyer for Shin & Kim based on his experience as a patent attorney, and successfully carried out patent infringement disputes, trade secret infringement disputes, and disputes over defects related to advanced technology such as next-generation card systems and plant facilities. He also provided advice on various deals that focus on the signing of joint technology development contracts and the transfer of IP and technology.

In addition, Mr. Jeong represented the injured company in the cases of major technology leaks that gained media attention (e.g., the case of overseas leakage of super-critical semiconductor cleaning equipment technology and the case of overseas outflow of lamination equipment technology) and won the cases, and in the case of prohibition of employee transfer for an employee who moved to Micron in the United States and prohibition of employee transfer for an employee who moved to a Chinese display company, he was the first in Korea to obtain an injunction ruling. Mr. Jeong was involved in the first domestic case (Seoul Central District Court 2014GaHap526972) regarding whether the original drug price reduction due to the release of a generic drug is subject to patent infringement and developed a new legal principle. Further, he led the en banc decision 2011Mo1839 by the Supreme Court, dated July 16, 2015, which provided a principled standard for determining whether a series of acts such as seizure, imaging, search, and reproduction of storage media by the prosecution were unlawful, highlighting his strength in areas where technology and legal principles overlap.

Trade secret disputes

• Represented clients in civil and criminal dispute over export cases of semiconductor cleaning equipment and super critical equipment technology.
• Represented clients in criminal dispute between Samsung Display and top tech companies on the leakage of the lamination technology.
• Represented clients in dispute related to the prohibition of employee transfer of major domestic companies such as Samsung Electronics, Samsung Display, and Samsung SDI.
• Represented clients in dispute over cancellation of disclosure of report on working environment measurement of Samsung Display.
• Represented clients in dispute over infringement of trade secrets related to the NF3 gas production facility for OCIM's semiconductor deposition cleaning use.
• Represented clients in dispute over infringement of trade secrets related to probiotic strain and mixing facility.
• Represented clients in dispute over infringement of trade secrets related to powdered metallurgical materials.
• Represented clients in dispute over infringement of trade secrets related to nano fibers.
• Represented clients in dispute over infringement of trade secrets related to the processing of silica, which is a raw material for LCD glass substrate.

Technical Disputes

• Represented clients in dispute between LG CNS, IBM, and BC Card on defects in next-generation card systems based on the main frame.
• Represented clients in dispute between Dongjin Semichem and Dongwoo Finechem over a technology transfer agreement.
• Represented clients in dispute over defects in the molybdenum leach plant and desulfurization plant of Seoul Sharp Heavy Industries.
• Represented clients in dispute over defects in computer control machinery by Doosan Infracore.
• Represented clients in dispute over ship engine defects.

Patent Disputes

• Represented clients in patent dispute between LMS and 3M over optical film packaging.
• Represented clients in dispute over patent infringement and invalidation trial (LCD) between Samsung Display and LG Display.
• Represented clients in patent dispute over PHPS, a semiconductor genome forming material, between UPI Chemical and AZEM.
• Represented clients in disputes between Hanmi Pharmaceutical and Eli Lilly over the reduction of Olanzapine’s drug price.
• Represented clients in patent invalidation and infringement of Nabtesco’s platform screen door system.
• Represented Shinwon RPC in a patent dispute over bridge construction method using PC plates.
• Represented clients in disputes over patents on metal plate cutting machines.
• Represented clients in patent dispute over database algorithms.
• Represented clients in dispute over patents for shooting game algorithms.
• Represented clients in dispute over connector patents and designs.
• Represented clients in patent dispute over the formulation of mycophenolate, an immunosuppressant.
• Represented clients in patent dispute between Tacoma Technology and BASF.
• Represented clients in dispute over the patent of Layla Tab, a natural pharmaceutical product.
• Represented clients in dispute over the use and substance of the erectile dysfunction treatment drug, Sildenafil (trademark name Viagra, Palpal Tab, etc.).
• Represented clients in dispute over the use, substance, and composition of patents related to general-purpose anticancer drug, Docetaxel (trade name Taxotere).
• Represented clients in dispute over the composition patent related to hypertension, Candesartan Cilexetil.
• Represented clients in dispute over the patent for Prebalin Cap, a painkiller.
• Represented clients in dispute over Olanzapine, a drug for depression, on whether the reduced drug price of the original drug caused by the release of a generic drug, is included in the amount of damages arising from patent infringement.
• Represented clients in dispute over the patent for Sodium Meta Arsenite, a universal anticancer drug/pain killer
• Represented clients in dispute over the patent for anti-virus agent Candesartan Cilexetil.
• Represented clients in dispute over the patent for rosuvastatin, heterozygous familial hypercholesterolemia drug.
• Represented clients in dispute over the refining method patents for the manufacture of VLPs of the type 16 and 18 L1 virus and HPV type for the prevention of cervical cancer.

Advisory Services

• Advised clients on IP in relation to the sale of CJ Healthcare.
• Advised clients on patents of compositions for semiconductor etching.
• Advised clients on joint technology development agreements, license agreements, M&A of domestic and foreign companies.
• Advised clients on domestic and foreign patents, trademarks, and copyright license agreements.

Criminal Disputes

• Represented clients in criminal dispute over M&A of CEOs of major domestic pharmaceutical companies (Seoul High Court Case 2012No265; Supreme Court Case 2012Do9475 dated March 27, 2014).
• Represented clients in re-appeal case on whether a series of acts of the Prosecutor, e.g., seizure, imaging, search, and reproduction of storage media is illegal (Supreme Court Decision 2011Mo1839 dated July 16, 2015, En banc).

Seminars

• Lecture on major issues in trade secret disputes at a seminar jointly organized by KIPLA and the Seoul Bar Association IPR Community.
• Lecture at the 69th CSO Training Course hosted by the Ministry of Trade, Industry and Energy and the Korean Association for Industrial Technology Security.
• Seminar hosted by Pangyo Gyeonggi Center for Creative Economy & Innovation (Subject: Key Points on Trade Secret Protection, Joint Technology Development Contracts).
• In-house lectures for Samsung Electronics, Samsung Display, and POSCO.
• Lectures hosted by Intellectual Property Research Institute of the Korean Intellectual Property Office.
• Seminar hosted by the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (Subject: Discussion Panel for Seminar on Regulation Under the Fair Trade Act on Anti-Competitive Agreements in the Pharmaceutical Market).